Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that President and co-CEO Sam Lee, PhD discussed the scientific foundation and clinical progress with the Company’s lead pan-viral protease inhibitor ...

Q1 2026 Earnings Call Transcript September 10, 2025 Daktronics, Inc. beats earnings expectations. Reported EPS is $0.33, ...

Title : APG990, a monoclonal antibody targeting OX40L, demonstrates safety and an extended half-life in healthy subjects (P3237) Presenter : Carl Dambkowski, M.D., Chief Medical Officer, Apogee ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 ...

The detailed results from the HARMONi trial—the first global phase 3 data set for the world’s first PD-1xVEGF bispecific, ...

Q2 2026 Earnings Call Transcript September 9, 2025 Cognyte Software Ltd. beats earnings expectations. Reported EPS is $0.08, ...

On Tuesday, April 8, the Office of Admissions released admission data for the Class of 2029 to The Argus following Regular Decision (RD) admissions decisions this March. This cycle saw the largest ...

AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced the presentation of updated clinical ...

Oral presentation will feature data demonstrating SCY-247 in vitro activity against C. auris strains, including isolates with mutations commonly ...

Arcus Biosciences, Inc. ( NYSE: RCUS) Citi's Biopharma Back to School Conference September 3, 2025 11:15 AM EDT So welcome, everyone. I'm Yigal Nochomovitz, Biotech Analyst at Citi. This is the Citi ...

Mineralys Therapeutics, Inc. stock jumped on promising lorundrostat hypertension data, sparking M&A buzz. Click for more on ...